{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T04:24:48Z","timestamp":1788582288257,"version":"build-2803163510"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nutr. Diabetes"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>Type 1 diabetes (T1D) is an autoimmune disorder that destroys insulin-generating pancreatic \u03b2-cells. Preserving pancreatic \u03b2-cell function is important for treating T1D. Our study aims to explore the mechanism underlying urolithin C (UC)-mediated regulation of \u03b2-cell function.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Non-obese diabetic (NOD) mice were administrated with UC to evaluate UC-mediated protection of T1D. The inflammation of the pancreas islets was examined by hematoxylin and eosin staining. Glucose-stimulated insulin secretion (GSIS) assay and oral glucose tolerance test were applied to evaluate the progression of T1D. MIN6 cells were treated with TNF-\u03b1, IL-1\u03b2 and IFN-\u03b3 in the presence of UC. Cell viability was analyzed by CCK-8. Cell apoptosis, proliferation and DNA fragmentation were examined by Annexin V-FITC and PI staining, EdU incorporation and comet assays. Keap1, Nrf2, HO-1 and NQO1 were examined by western blot. Immunofluorescence staining was applied to detect Nrf2 and insulin.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>UC administration significantly reduced diabetes incidence, attenuated insulitis, elevated insulin levels and GSIS and reduced blood glucose and AUC in NOD mice. Cytokine treatment suppressed MIN6 cell viability and proliferation but enhanced apoptosis and DNA damage, and these detrimental effects were relieved by UC treatment. Furthermore, UC administration inhibited Keap1 expression and promoted the expression of Nrf2, HO-1 and NQO1 in NOD mice. Nrf2 signaling has been reported to be implicated in preventing the onset of diabetes, and HO-1 and NQO1 are phase II antioxidant enzymes that are regulated by Nrf2 signaling. Cytokine treatment upregulated Keap1 and downregulated Nrf2, HO-1 and NQO1 in MIN6 cells, but it was reversed by UC. The nuclear translocation of Nrf2 was prevented by cytokine treatment, but UC promoted its nuclear translocation. UC-mediated upregulation of Nrf2, HO-1 and NQO1, decreased cell apoptosis and increased proliferation and insulin secretion were abolished by silencing of Nrf2.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>UC improves pancreatic \u03b2-cell function by activating Nrf2 signaling, thereby alleviating T1D progression.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1038\/s41387-023-00253-3","type":"journal-article","created":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T05:03:32Z","timestamp":1701407012000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Urolithin C alleviates pancreatic \u03b2-cell dysfunction in type 1 diabetes by activating Nrf2 signaling"],"prefix":"10.1038","volume":"13","author":[{"given":"Cheng","family":"Luo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Can","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danyi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5856-7881","authenticated-orcid":false,"given":"Chen","family":"Chao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,12,1]]},"reference":[{"key":"253_CR1","doi-asserted-by":"publisher","first-page":"17016","DOI":"10.1038\/nrdp.2017.16","volume":"3","author":"A Katsarou","year":"2017","unstructured":"Katsarou A, Gudbjornsdottir S, Rawshani A, Dabelea D, Bonifacio E, Anderson BJ, et al. Type 1 diabetes mellitus. Nat Rev Dis Prim. 2017;3:17016.","journal-title":"Nat Rev Dis Prim"},{"key":"253_CR2","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/j.ecl.2010.05.011","volume":"39","author":"DM Maahs","year":"2010","unstructured":"Maahs DM, West NA, Lawrence JM, Mayer-Davis EJ. Epidemiology of type 1 diabetes. Endocrinol Metab Clin North Am. 2010;39:481\u201397.","journal-title":"Endocrinol Metab Clin North Am"},{"key":"253_CR3","doi-asserted-by":"publisher","first-page":"98","DOI":"10.34172\/hpp.2020.18","volume":"10","author":"M Mobasseri","year":"2020","unstructured":"Mobasseri M, Shirmohammadi M, Amiri T, Vahed N, Hosseini Fard H, Ghojazadeh M. Prevalence and incidence of type 1 diabetes in the world: a systematic review and meta-analysis. Health Promot Perspect. 2020;10:98\u2013115.","journal-title":"Health Promot Perspect"},{"key":"253_CR4","doi-asserted-by":"publisher","first-page":"e000161","DOI":"10.1136\/bmjdrc-2015-000161","volume":"4","author":"WP You","year":"2016","unstructured":"You WP, Henneberg M. Type 1 diabetes prevalence increasing globally and regionally: the role of natural selection and life expectancy at birth. BMJ Open Diabetes Res Care. 2016;4:e000161.","journal-title":"BMJ Open Diabetes Res Care"},{"key":"253_CR5","doi-asserted-by":"publisher","first-page":"131","DOI":"10.4161\/isl.3.4.15728","volume":"3","author":"P In\u2019t Veld","year":"2011","unstructured":"In\u2019t Veld P. Insulitis in human type 1 diabetes: the quest for an elusive lesion. Islets. 2011;3:131\u20138.","journal-title":"Islets"},{"key":"253_CR6","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1152\/physrev.00008.2017","volume":"98","author":"P Rorsman","year":"2018","unstructured":"Rorsman P, Ashcroft FM. Pancreatic beta-cell electrical activity and insulin secretion: of mice and men. Physiol Rev. 2018;98:117\u2013214.","journal-title":"Physiol Rev"},{"key":"253_CR7","doi-asserted-by":"publisher","first-page":"343","DOI":"10.3389\/fendo.2017.00343","volume":"8","author":"AL Burrack","year":"2017","unstructured":"Burrack AL, Martinov T, Fife BT. T cell-mediated beta cell destruction: autoimmunity and alloimmunity in the context of type 1 diabetes. Front Endocrinol. 2017;8:343.","journal-title":"Front Endocrinol"},{"key":"253_CR8","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1097\/MED.0000000000000548","volume":"27","author":"EK Sims","year":"2020","unstructured":"Sims EK, Mirmira RG, Evans-Molina C. The role of beta-cell dysfunction in early type 1 diabetes. Curr Opin Endocrinol Diabetes Obes. 2020;27:215\u201324.","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"253_CR9","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1016\/j.cmet.2018.09.011","volume":"29","author":"C Guay","year":"2019","unstructured":"Guay C, Kruit JK, Rome S, Menoud V, Mulder NL, Jurdzinski A, et al. Lymphocyte-derived exosomal microRNAs promote pancreatic beta cell death and may contribute to type 1 diabetes development. Cell Metab. 2019;29:348\u201361.e346.","journal-title":"Cell Metab"},{"key":"253_CR10","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.1172\/JCI200113785","volume":"108","author":"E Bernal-Mizrachi","year":"2001","unstructured":"Bernal-Mizrachi E, Wen W, Stahlhut S, Welling CM, Permutt MA. Islet beta cell expression of constitutively active Akt1\/PKB alpha induces striking hypertrophy, hyperplasia, and hyperinsulinemia. J Clin Investig. 2001;108:1631\u20138.","journal-title":"J Clin Investig"},{"key":"253_CR11","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1007\/s00125-014-3175-2","volume":"57","author":"E Hakonen","year":"2014","unstructured":"Hakonen E, Ustinov J, Eizirik DL, Sariola H, Miettinen PJ, Otonkoski T. In vivo activation of the PI3K-Akt pathway in mouse beta cells by the EGFR mutation L858R protects against diabetes. Diabetologia. 2014;57:970\u20139.","journal-title":"Diabetologia"},{"key":"253_CR12","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1016\/j.jnutbio.2009.04.012","volume":"21","author":"M Larrosa","year":"2010","unstructured":"Larrosa M, Gonzalez-Sarrias A, Yanez-Gascon MJ, Selma MV, Azorin-Ortuno M, Toti S, et al. Anti-inflammatory properties of a pomegranate extract and its metabolite urolithin-A in a colitis rat model and the effect of colon inflammation on phenolic metabolism. J Nutr Biochem. 2010;21:717\u201325.","journal-title":"J Nutr Biochem"},{"key":"253_CR13","doi-asserted-by":"publisher","first-page":"10181","DOI":"10.1021\/jf9025794","volume":"57","author":"D Bialonska","year":"2009","unstructured":"Bialonska D, Kasimsetty SG, Khan SI, Ferreira D. Urolithins, intestinal microbial metabolites of Pomegranate ellagitannins, exhibit potent antioxidant activity in a cell-based assay. J Agric food Chem. 2009;57:10181\u20136.","journal-title":"J Agric food Chem"},{"key":"253_CR14","doi-asserted-by":"publisher","first-page":"647582","DOI":"10.3389\/fnut.2021.647582","volume":"8","author":"SA Al-Harbi","year":"2021","unstructured":"Al-Harbi SA, Abdulrahman AO, Zamzami MA, Khan MI. Urolithins: the gut based polyphenol metabolites of ellagitannins in cancer prevention, a review. Front Nutr. 2021;8:647582.","journal-title":"Front Nutr"},{"key":"253_CR15","doi-asserted-by":"crossref","unstructured":"Raimundo AF, Ferreira S, Tomas-Barberan FA, Santos CN, Menezes R. Urolithins: diet-derived bioavailable metabolites to tackle diabetes. Nutrients. 2021;13:4285.","DOI":"10.3390\/nu13124285"},{"key":"253_CR16","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-017-0561-3","volume":"16","author":"M Savi","year":"2017","unstructured":"Savi M, Bocchi L, Mena P, Dall\u2019Asta M, Crozier A, Brighenti F, et al. In vivo administration of urolithin A and B prevents the occurrence of cardiac dysfunction in streptozotocin-induced diabetic rats. Cardiovasc Diabetol. 2017;16:80.","journal-title":"Cardiovasc Diabetol"},{"key":"253_CR17","doi-asserted-by":"publisher","first-page":"4065","DOI":"10.1111\/bph.14821","volume":"176","author":"M Bayle","year":"2019","unstructured":"Bayle M, Neasta J, Dall\u2019Asta M, Gautheron G, Virsolvy A, Quignard JF, et al. The ellagitannin metabolite urolithin C is a glucose-dependent regulator of insulin secretion through activation of L-type calcium channels. Br J Pharmacol. 2019;176:4065\u201378.","journal-title":"Br J Pharmacol"},{"key":"253_CR18","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1016\/j.bbadis.2016.11.005","volume":"1863","author":"SM Ahmed","year":"2017","unstructured":"Ahmed SM, Luo L, Namani A, Wang XJ, Tang X. Nrf2 signaling pathway: Pivotal roles in inflammation. Biochim Biophys Acta Mol Basis Dis. 2017;1863:585\u201397.","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"253_CR19","doi-asserted-by":"crossref","unstructured":"Yagishita Y, Uruno A, Chartoumpekis DV, Kensler TW, Yamamoto M. Nrf2 represses the onset of type 1 diabetes in non-obese diabetic mice. J Endocrinol. 2019:JOE-18-0355.R2.","DOI":"10.1530\/JOE-18-0355"},{"key":"253_CR20","doi-asserted-by":"publisher","first-page":"7866720","DOI":"10.1155\/2021\/7866720","volume":"2021","author":"Y Lou","year":"2021","unstructured":"Lou Y, Kong M, Li L, Hu Y, Zhai W, Qi X, et al. Inhibition of the Keap1\/Nrf2 signaling pathway significantly promotes the progression of type 1 diabetes mellitus. Oxid Med Cell Longev. 2021;2021:7866720.","journal-title":"Oxid Med Cell Longev"},{"key":"253_CR21","doi-asserted-by":"crossref","unstructured":"Baird L, Yamamoto M. The molecular mechanisms regulating the KEAP1-NRF2 pathway. Mol Cell Biol. 2020;40:e00099-20.","DOI":"10.1128\/MCB.00099-20"},{"key":"253_CR22","doi-asserted-by":"publisher","first-page":"732596","DOI":"10.1155\/2015\/732596","volume":"2015","author":"DR Bruns","year":"2015","unstructured":"Bruns DR, Drake JC, Biela LM, Peelor FF III, Miller BF, Hamilton KL. Nrf2 signaling and the slowed aging phenotype: evidence from long-lived models. Oxid Med Cell Longev. 2015;2015:732596.","journal-title":"Oxid Med Cell Longev"},{"key":"253_CR23","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s10020-022-00444-1","volume":"28","author":"P Chen","year":"2022","unstructured":"Chen P, Pei J, Wang X, Tai S, Tang L, Hu X. Gut bacterial metabolite Urolithin A inhibits myocardial fibrosis through activation of Nrf2 pathway in vitro and in vivo. Mol Med. 2022;28:19.","journal-title":"Mol Med"},{"key":"253_CR24","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1038\/nprot.2009.150","volume":"4","author":"DS Li","year":"2009","unstructured":"Li DS, Yuan YH, Tu HJ, Liang QL, Dai LJ. A protocol for islet isolation from mouse pancreas. Nat Protoc. 2009;4:1649\u201352.","journal-title":"Nat Protoc"},{"key":"253_CR25","doi-asserted-by":"publisher","first-page":"153741","DOI":"10.1016\/j.phymed.2021.153741","volume":"93","author":"Y Zhang","year":"2021","unstructured":"Zhang Y, Aisker G, Dong H, Halemahebai G, Zhang Y, Tian L. Urolithin A suppresses glucolipotoxicity-induced ER stress and TXNIP\/NLRP3\/IL-1beta inflammation signal in pancreatic beta cells by regulating AMPK and autophagy. Phytomedicine. 2021;93:153741.","journal-title":"Phytomedicine"},{"key":"253_CR26","doi-asserted-by":"publisher","first-page":"2996","DOI":"10.1128\/MCB.00225-13","volume":"33","author":"A Uruno","year":"2013","unstructured":"Uruno A, Furusawa Y, Yagishita Y, Fukutomi T, Muramatsu H, Negishi T, et al. The Keap1-Nrf2 system prevents onset of diabetes mellitus. Mol Cell Biol. 2013;33:2996\u20133010.","journal-title":"Mol Cell Biol"},{"key":"253_CR27","doi-asserted-by":"publisher","first-page":"2146","DOI":"10.7150\/ijbs.69116","volume":"18","author":"Z Gao","year":"2022","unstructured":"Gao Z, Yi W, Tang J, Sun Y, Huang J, Lan T, et al. Urolithin A protects against acetaminophen-induced liver injury in mice via sustained activation of Nrf2. Int J Biol Sci. 2022;18:2146\u201362.","journal-title":"Int J Biol Sci"},{"key":"253_CR28","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1007\/128_2012_339","volume":"329","author":"TW Kensler","year":"2013","unstructured":"Kensler TW, Egner PA, Agyeman AS, Visvanathan K, Groopman JD, Chen JG, et al. Keap1-nrf2 signaling: a target for cancer prevention by sulforaphane. Top Curr Chem. 2013;329:163\u201377.","journal-title":"Top Curr Chem"},{"key":"253_CR29","doi-asserted-by":"publisher","first-page":"6730","DOI":"10.4049\/jimmunol.181.10.6730","volume":"181","author":"SA Rushworth","year":"2008","unstructured":"Rushworth SA, MacEwan DJ, O\u2019Connell MA. Lipopolysaccharide-induced expression of NAD(P)H:quinone oxidoreductase 1 and heme oxygenase-1 protects against excessive inflammatory responses in human monocytes. J Immunol. 2008;181:6730\u20137.","journal-title":"J Immunol"},{"key":"253_CR30","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1038\/s41574-022-00690-7","volume":"18","author":"D Tomic","year":"2022","unstructured":"Tomic D, Shaw JE, Magliano DJ. The burden and risks of emerging complications of diabetes mellitus. Nat Rev Endocrinol. 2022;18:525\u201339.","journal-title":"Nat Rev Endocrinol"},{"key":"253_CR31","doi-asserted-by":"publisher","first-page":"2741","DOI":"10.1007\/s00125-021-05571-8","volume":"64","author":"A Green","year":"2021","unstructured":"Green A, Hede SM, Patterson CC, Wild SH, Imperatore G, Roglic G, et al. Type 1 diabetes in 2017: global estimates of incident and prevalent cases in children and adults. Diabetologia. 2021;64:2741\u201350.","journal-title":"Diabetologia"},{"key":"253_CR32","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1111\/fcp.12551","volume":"34","author":"S Toubal","year":"2020","unstructured":"Toubal S, Oiry C, Bayle M, Cros G, Neasta J. Urolithin C increases glucose-induced ERK activation which contributes to insulin secretion. Fundam Clin Pharmacol. 2020;34:571\u201380.","journal-title":"Fundam Clin Pharmacol"},{"key":"253_CR33","doi-asserted-by":"publisher","first-page":"37","DOI":"10.3389\/fendo.2013.00037","volume":"4","author":"ME Cerf","year":"2013","unstructured":"Cerf ME. Beta cell dysfunction and insulin resistance. Front Endocrinol. 2013;4:37.","journal-title":"Front Endocrinol"},{"key":"253_CR34","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.jaut.2016.03.014","volume":"71","author":"D Saunders","year":"2016","unstructured":"Saunders D, Powers AC. Replicative capacity of beta-cells and type 1 diabetes. J Autoimmun. 2016;71:59\u201368.","journal-title":"J Autoimmun"},{"key":"253_CR35","doi-asserted-by":"publisher","first-page":"9232","DOI":"10.1073\/pnas.0602956103","volume":"103","author":"C Le May","year":"2006","unstructured":"Le May C, Chu K, Hu M, Ortega CS, Simpson ER, Korach KS, et al. Estrogens protect pancreatic beta-cells from apoptosis and prevent insulin-deficient diabetes mellitus in mice. Proc Natl Acad Sci USA. 2006;103:9232\u20137.","journal-title":"Proc Natl Acad Sci USA"},{"key":"253_CR36","doi-asserted-by":"publisher","first-page":"113628","DOI":"10.1016\/j.jep.2020.113628","volume":"272","author":"Y Zhang","year":"2021","unstructured":"Zhang Y, Zhang Y, Halemahebai G, Tian L, Dong H, Aisker G. Urolithin A, a pomegranate metabolite, protects pancreatic beta cells from apoptosis by activating autophagy. J Ethnopharmacol. 2021;272:113628.","journal-title":"J Ethnopharmacol"},{"key":"253_CR37","doi-asserted-by":"crossref","unstructured":"Peipei Yin JZ, Linlin Y, Lingguang Y, Liwei S, Lingling S, Chao M, et al. Urolithin C, a gut metabolite of ellagic acid, induces apoptosis in PC12 cells through a mitochondria-mediated pathway. RSC Adv. 2017;7:17254.","DOI":"10.1039\/C7RA01548H"},{"key":"253_CR38","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1146\/annurev-pharmtox-011112-140320","volume":"53","author":"Q Ma","year":"2013","unstructured":"Ma Q. Role of nrf2 in oxidative stress and toxicity. Annu Rev Pharmacol Toxicol. 2013;53:401\u201326.","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"253_CR39","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1016\/j.bbamcr.2018.02.010","volume":"1865","author":"I Bellezza","year":"2018","unstructured":"Bellezza I, Giambanco I, Minelli A, Donato R. Nrf2-Keap1 signaling in oxidative and reductive stress. Biochim Biophys Acta Mol Cell Res. 2018;1865:721\u201333.","journal-title":"Biochim Biophys Acta Mol Cell Res"},{"key":"253_CR40","doi-asserted-by":"publisher","first-page":"1675957","DOI":"10.1155\/2020\/1675957","volume":"2020","author":"EHM Hassanein","year":"2020","unstructured":"Hassanein EHM, Sayed AM, Hussein OE, Mahmoud AM. Coumarins as modulators of the Keap1\/Nrf2\/ARE signaling pathway. Oxid Med Cell Longev. 2020;2020:1675957.","journal-title":"Oxid Med Cell Longev"},{"key":"253_CR41","doi-asserted-by":"publisher","first-page":"605","DOI":"10.2337\/db13-0909","volume":"63","author":"Y Yagishita","year":"2014","unstructured":"Yagishita Y, Fukutomi T, Sugawara A, Kawamura H, Takahashi T, Pi J, et al. Nrf2 protects pancreatic beta-cells from oxidative and nitrosative stress in diabetic model mice. Diabetes. 2014;63:605\u201318.","journal-title":"Diabetes"},{"key":"253_CR42","doi-asserted-by":"publisher","first-page":"989","DOI":"10.2337\/db21-0581","volume":"71","author":"S Baumel-Alterzon","year":"2022","unstructured":"Baumel-Alterzon S, Katz LS, Brill G, Jean-Pierre C, Li Y, Tse I, et al. Nrf2 regulates beta-cell mass by suppressing beta-cell death and promoting beta-cell proliferation. Diabetes. 2022;71:989\u20131011.","journal-title":"Diabetes"},{"key":"253_CR43","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.tem.2020.11.002","volume":"32","author":"S Baumel-Alterzon","year":"2021","unstructured":"Baumel-Alterzon S, Katz LS, Brill G, Garcia-Ocana A, Scott DK. Nrf2: the master and captain of beta cell fate. Trends Endocrinol Metab. 2021;32:7\u201319.","journal-title":"Trends Endocrinol Metab"},{"key":"253_CR44","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.4049\/jimmunol.2100355","volume":"207","author":"VE Burns","year":"2021","unstructured":"Burns VE, Kerppola TK. Virus infection induces Keap1 binding to cytokine genes, which recruits NF-kappaB p50 and G9a-GLP and represses cytokine transcription. J Immunol. 2021;207:1437\u201347.","journal-title":"J Immunol"}],"container-title":["Nutrition &amp; Diabetes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41387-023-00253-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41387-023-00253-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41387-023-00253-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T05:04:24Z","timestamp":1701407064000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41387-023-00253-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,1]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["253"],"URL":"https:\/\/doi.org\/10.1038\/s41387-023-00253-3","relation":{},"ISSN":["2044-4052"],"issn-type":[{"value":"2044-4052","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,1]]},"assertion":[{"value":"6 April 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 November 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 December 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The study was approved by the Animal Care and Use Committee of the Second Xiangya Hospital of Central South University, and in compliance with the Guide for the Care and Use of Laboratory Animals.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"24"}}